Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capsular polysaccharides of Neisseria meningitidis serogroups A, C, W, and Y are surface-exposed sugar polymers that serve as major virulence factors, protecting the bacteria from host immune defenses. These polysaccharides are the targets of quadrivalent meningococcal conjugate vaccines, which elicit protective antibody responses that promote bacterial clearance through opsonization and complement activation. The chemical structure of each serogroup's polysaccharide is distinct, with serogroup A composed of N-acetyl mannosamine-1-phosphate, serogroup C of polysialic acid, and serogroups W and Y of sialic acid polymers with unique linkages. Conjugation to a carrier protein like tetanus toxoid or diphtheria toxoid enhances the immunogenicity of these polysaccharides, especially in infants and young children.
Vaccine-induced antibodies bind to the capsular polysaccharides, promoting complement activation and opsonophagocytosis, leading to bacterial clearance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis serogroups A, C, W, and Y capsular polysaccharides (ACWY capsular polysaccharides).